Identification of two hub genes and miRNA‑mRNA interactions in chronic obstructive pulmonary disease (COPD) plasma

References

• Agustí A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1248–1256. doi:10.1056/NEJMra1900475.
   PubMed Web of Science ®Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651. doi:10.1183/13993003.00651-2019.
   PubMed Web of Science ®Google Scholar
• Zhu M, Ye M, Wang J, Ye L, Jin M. Construction of potential miRNA-mRNA regulatory network in COPD plasma by bioinformatics analysis. Int J Chron Obstruct Pulmon Dis. 2020;15:2135–2145. doi:10.2147/COPD.S255262.
   PubMed Web of Science ®Google Scholar
• Singh D, Roche N, Halpin D, Agusti A, Wedzicha JA, Martinez FJ. Current controversies in the pharmacological treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(5):541–549. doi:10.1164/rccm.201606-1179PP.
   PubMed Web of Science ®Google Scholar
• Lindberg A, Eriksson B, Larsson L-G, Rönmark E, Sandström T, Lundbäck B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. CHEST. 2006;129(4):879–885. doi:10.1378/chest.129.4.879.
   PubMed Web of Science ®Google Scholar
• Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. THORAX. 2006;61(11):935–939. doi:10.1136/thx.2006.062802.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355. doi:10.1038/nature02871.
   PubMed Web of Science ®Google Scholar
• Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769–773. doi:10.1038/nature03315.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. CELL. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Wittstatt J, Weider M, Wegner M, Reiprich S. MicroRNA miR-204 regulates proliferation and differentiation of oligodendroglia in culture. GLIA. 2020;68(10):2015–2027. doi:10.1002/glia.23821.
   PubMed Web of Science ®Google Scholar
• Conickx G, Mestdagh P, Avila Cobos F, Verhamme FM, Maes T, Vanaudenaerde BM, Seys LJM, Lahousse L, Kim RY, Hsu AC, et al. MicroRNA profiling reveals a role for MicroRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(1):43–56. doi:10.1164/rccm.201506-1182OC.
   PubMed Web of Science ®Google Scholar
• Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, Lu J, Liu G, Zhang X, Bowers J, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A. 2009;106(7):2319–2324. doi:10.1073/pnas.0806383106.
   PubMed Web of Science ®Google Scholar
• Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Sun J, Michalski J, et al. Reduced miR-146a increases prostaglandin E-2 in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2010;182(8):1020–1029. doi:10.1164/rccm.201001-0055OC.
   PubMed Web of Science ®Google Scholar
• Castillo D, Burgos F, Guayta R, Giner J, Lozano P, Estrada M, Soriano JB, Flor X, Barau M, Casan P, et al. Airflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosis. Respir Med. 2015;109(4):475–482. doi:10.1016/j.rmed.2015.02.009.
   PubMed Web of Science ®Google Scholar
• Davis KJ, Landis SH, Oh Y-M, Mannino DM, Han MK, van der Molen T, Aisanov Z, Menezes AM, Ichinose M, Muellerova H, et al. Continuing to confront COPD international physician survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis. 2015;10:39–55. doi:10.2147/COPD.S70162.
   PubMed Web of Science ®Google Scholar
• Burney P, Jarvis D, Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis. 2015;19(1):10–20. doi:10.5588/ijtld.14.0446.
   PubMed Web of Science ®Google Scholar
• Halldin CN, Doney BC, Hnizdo E. Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors. Chron Respir Dis. 2015;12(1):47–60. doi:10.1177/1479972314562409.
   PubMed Web of Science ®Google Scholar
• Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(7):554–564. doi:10.1513/pats.200701-003FM.
   PubMedGoogle Scholar
• Melville AM, Pless-Mulloli T, Afolabi OA, Stenton SC. COPD prevalence and its association with occupational exposures in a general population. Eur Respir J. 2010;36(3):488–493. doi:10.1183/09031936.00038309.
   PubMed Web of Science ®Google Scholar
• Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J. 2006;28(4):781–785. doi:10.1183/09031936.06.00152205.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zou Y, Li X, Chen S, Zhao Z, He F, Zou W, Luo Q, Li W, Pan Y, et al. Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study. PLoS Med. 2014;11(3):e1001621. doi:10.1371/journal.pmed.1001621.
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2(1):54–62. doi:10.1016/S2213-2600(13)70232-7.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR, Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly An official American thoracic society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. doi:10.1164/rccm.200811-1757ST.
   PubMed Web of Science ®Google Scholar
• Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3.
   PubMed Web of Science ®Google Scholar
• Sun XJ, Chen L, He ZY. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr Drug Metab. 2019;20(4):301–304. doi:10.2174/1389200220666190227224748.
   PubMed Web of Science ®Google Scholar
• Li YL. The role of the PI3K/AKT/mTOR protein synthesis pathway in the skeletal muscle atrophy induced by COPD. Int J Clin Exp Med. 2016;9(3):5677–5687.
   Web of Science ®Google Scholar
• Zhang HX, et al. HIF-1 alpha promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(18):6077–6084.
   PubMed Web of Science ®Google Scholar
• Wang L, Jiang W, Wang J, Xie Y, Wang W. Puerarin inhibits FUNDC1-mediated mitochondrial autophagy and CSE-induced apoptosis of human bronchial epithelial cells by activating the PI3K/AKT/mTOR signaling pathway. Aging (Albany NY). 2022;14(3):1253–1264. doi:10.18632/aging.203317.
   PubMedGoogle Scholar
• Shi J, Ye J, Fei H, Jiang S-H, Wu Z-Y, Chen Y-P, Zhang L-W, Yang X-M. YWHAZ promotes ovarian cancer metastasis by modulating glycolysis. Oncol Rep. 2019;41(2):1101–1112. doi:10.3892/or.2018.6920.
   PubMed Web of Science ®Google Scholar
• Liu W, Hu W, Hou K, Zhu S. Circular RNA paired-related homeobox 1 promotes gastric carcinoma cell progression via regulating microRNA-665/YWHAZ axis. Dig Dis Sci. 2021;66(11):3842–3853. doi:10.1007/s10620-020-06705-5.
   PubMed Web of Science ®Google Scholar
• Deng Y, Zheng JY, Ma JG. The clinical and prognostic significance of YWHAZ in non-small-cell lung cancer patients: immunohistochemical analysis. J Cell Biochem. 2019;120(4):6290–6298. doi:10.1002/jcb.27915.
   PubMed Web of Science ®Google Scholar
• Shen Z, Chai T, Luo F, Liu Z, Xu H, Zhang P, Kang M, Chen S. Loss of miR-204-5p promotes tumor proliferation, migration, and invasion through targeting YWHAZ/PI3K/AKT pathway in esophageal squamous cell carcinoma. Onco Targets Ther. 2020;13:4679–4690. doi:10.2147/OTT.S243215.
   PubMed Web of Science ®Google Scholar
• Guo C, Liu S, Wang J, Sun M-Z, Greenaway FT. ACTB in cancer. Clin Chim Acta. 2013;417:39–44. doi:10.1016/j.cca.2012.12.012.
   PubMed Web of Science ®Google Scholar
• Gu Y, Tang S, Wang Z, Cai L, Lian H, Shen Y, Zhou Y. A pan-cancer analysis of the prognostic and immunological role of beta-actin (ACTB) in human cancers. Bioengineered. 2021;12(1):6166–6185. doi:10.1080/21655979.2021.1973220.
   PubMed Web of Science ®Google Scholar
• Li Y, Ma H, Shi C, Feng F, Yang L. Mutant ACTB mRNA 3 ‘-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a. Cell Signal. 2020;67:109479. doi:10.1016/j.cellsig.2019.109479.
   PubMed Web of Science ®Google Scholar
• Ito M, Hiwasa T, Yajima S, Suzuki T, Oshima Y, Nanami T, Sumazaki M, Shiratori F, Li S-Y, Iwadate Y, et al. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma. Esophagus. 2022;19(4):617–625. doi:10.1007/s10388-022-00939-0.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhou T, Xie G, Fu S, Gao L, Liao J, Wu Y, Wang G. Proteomics of exhaled breath condensate in stable COPD and non-COPD controls using tandem mass tags (TMTs) quantitative mass spectrometry: a pilot study. J Proteomics. 2019;206:103392. doi:10.1016/j.jprot.2019.103392.
   PubMed Web of Science ®Google Scholar
• Liu T. miR-937 serves as an inflammatory inhibitor in cigarette smoke extract-induced human bronchial epithelial cells by targeting IL1B and regulating TNF-alpha/IL-17 signaling pathway. Tob Induc Dis. 2021;19(July). doi:10.18332/tid/138227.
   Google Scholar
• Cao Z, et al. microRNA-183 down-regulates the expression of BKCa beta 1 protein that is related to the severity of chronic obstructive pulmonary disease. Hippokratia. 2014;18(4):328–332.
   PubMed Web of Science ®Google Scholar
• Wang XD, et al. Resveratrol inhibits dysfunction of dendritic cells from chronic obstructive pulmonary disease patients through promoting miR-34. Int J Clin Exp Path. 2015;8(5):5145–5152.
   PubMed Web of Science ®Google Scholar
• Wang C, Feng D, Dong S, He R, Fan B. Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines. J Clin Lab Anal. 2022;36(3):e24204. doi:10.1002/jcla.24204.
   PubMed Web of Science ®Google Scholar